Skip to main content
Top
Published in: Journal on Data Semantics 4/2018

10-09-2018 | Original Article

Imaging Biomarker Ontology (IBO): A Biomedical Ontology to Annotate and Share Imaging Biomarker Data

Authors: Emna Amdouni, Bernard Gibaud

Published in: Journal on Data Semantics | Issue 4/2018

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Imaging biomarkers refer to radiological measurements that characterize biological processes of imaged subjects and help clinicians particularly in the assessment of therapeutic responses and the early prediction of pathologies. Several imaging features (size of a lesion, volume of a tumor, blood perfusion in a specific anatomical region, anisotropic water diffusion in a particular tissue region, etc.) are quantified and reported in the clinical practice. The growth of the number of research studies addressing imaging biomarkers and the increasing use of these measurements in the radiological routine necessitates the use of semantic research tools. The use of semantic technologies will enable to efficiently retrieve imaging-related data and to enhance the interoperability in the biomedical field. While many efforts have been conducted regarding the definition of a standardized vocabulary to support the sharing of the imaging biomarker knowledge, the definition of the term “imaging biomarker” stills inconsistent. In this paper, we introduce our motivation for semantically describing this concept and we outline shortcomings of the state-of-the-art methods. Here, we propose a semantic representation of the imaging biomarker concept that is based on the articulation of its three main semantic axes, namely the measured quality, the measurement tool and the decision tool. The developed ontology is called the Imaging Biomarker Ontology (IBO) and uses existing biomedical ontologies. A preliminary use case is studied to illustrate the utility of IBO in annotating quantitative and qualitative imaging data from the TCGA (The Cancer Genome Atlas) collection.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Abramson RG, Yankeelov TE (2014) Imaging biomarkers and surrogate endpoints in oncology clinical trials. In: Luna A, Vilanova JC, Hygino Da Cruz Jr LC, Rossi SE Functional imaging in oncology. Springer, Berlin, pp 29–42 Abramson RG, Yankeelov TE (2014) Imaging biomarkers and surrogate endpoints in oncology clinical trials. In: Luna A, Vilanova JC, Hygino Da Cruz Jr LC, Rossi SE Functional imaging in oncology. Springer, Berlin, pp 29–42
2.
go back to reference Asslaber M, Zatloukal K (2007) Biobanks: transnational, European and global networks. Brief Funct Genom Proteom 6(3):193–201CrossRef Asslaber M, Zatloukal K (2007) Biobanks: transnational, European and global networks. Brief Funct Genom Proteom 6(3):193–201CrossRef
3.
go back to reference Ball JR, Micheel CM et al (2010) Evaluation of biomarkers and surrogate endpoints in chronic disease. National Academies Press, Washington Ball JR, Micheel CM et al (2010) Evaluation of biomarkers and surrogate endpoints in chronic disease. National Academies Press, Washington
4.
go back to reference Bosmans JML, Peremans L, Menni M, De Schepper AM, Duyck PO, Parizel PM (2012) Structured reporting: if, why, when, how and at what expense? Results of a focus group meeting of radiology professionals from eight countries. Insights Imaging 3(3):295–302CrossRef Bosmans JML, Peremans L, Menni M, De Schepper AM, Duyck PO, Parizel PM (2012) Structured reporting: if, why, when, how and at what expense? Results of a focus group meeting of radiology professionals from eight countries. Insights Imaging 3(3):295–302CrossRef
5.
go back to reference Brinkman RR, Courtot M, Derom D, Fostel J, He Y, Lord PW, Malone J, Parkinson HE, Peters B, Rocca-Serra P et al (2010) Modeling biomedical experimental processes with OBI. J Biomed Semant 1(S–1):S7CrossRef Brinkman RR, Courtot M, Derom D, Fostel J, He Y, Lord PW, Malone J, Parkinson HE, Peters B, Rocca-Serra P et al (2010) Modeling biomedical experimental processes with OBI. J Biomed Semant 1(S–1):S7CrossRef
6.
go back to reference Brochhausen M, Zheng J, Birtwell D, Williams H, Masci AM, Ellis HJ, Stoeckert CJ (2016) OBIB-a novel ontology for biobanking. J Biomed Semant 7(1):23CrossRef Brochhausen M, Zheng J, Birtwell D, Williams H, Masci AM, Ellis HJ, Stoeckert CJ (2016) OBIB-a novel ontology for biobanking. J Biomed Semant 7(1):23CrossRef
7.
go back to reference Brunnbauer M (2013) Dicom metadata as rdf. In: GI-Jahrestagung, pp 1796–1804 Brunnbauer M (2013) Dicom metadata as rdf. In: GI-Jahrestagung, pp 1796–1804
8.
go back to reference Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC (2011) A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology 258(3):906–914CrossRef Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC (2011) A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology 258(3):906–914CrossRef
9.
go back to reference Buckler AJ, Paik D, Ouellette M, Danagoulian J, Wernsing G, Suzek BE (2013b) A novel knowledge representation framework for the statistical validation of quantitative imaging biomarkers. J Digit Imaging 26(4):614–629CrossRef Buckler AJ, Paik D, Ouellette M, Danagoulian J, Wernsing G, Suzek BE (2013b) A novel knowledge representation framework for the statistical validation of quantitative imaging biomarkers. J Digit Imaging 26(4):614–629CrossRef
10.
go back to reference Buckler AJ, Ouellette M, Danagoulian J, Wernsing G, Liu TT, Savig E, Suzek BE, Paik D, Rubin DL (2013a) Quantitative imaging biomarker ontology (QIBO) for knowledge representation of biomedical imaging biomarkers. J Digit Imaging 26(4):630–641CrossRef Buckler AJ, Ouellette M, Danagoulian J, Wernsing G, Liu TT, Savig E, Suzek BE, Paik D, Rubin DL (2013a) Quantitative imaging biomarker ontology (QIBO) for knowledge representation of biomedical imaging biomarkers. J Digit Imaging 26(4):630–641CrossRef
11.
go back to reference Ceusters W (2012) An information artifact ontology perspective on data collections and associated representational artifacts. In: MIE, pp 68–72 Ceusters W (2012) An information artifact ontology perspective on data collections and associated representational artifacts. In: MIE, pp 68–72
12.
go back to reference Ceusters W, Smith B (2015) Biomarkers in the ontology for general medical science. In: Cornet R (ed) Digital healthcare empowering Europeans, vol 512, no 8, pp 155–159 Ceusters W, Smith B (2015) Biomarkers in the ontology for general medical science. In: Cornet R (ed) Digital healthcare empowering Europeans, vol 512, no 8, pp 155–159
13.
go back to reference Channin DS, Mongkolwat P, Kleper V, Sepukar K, Rubin DL (2010) The caBIG annotation and image markup project. J Digit Imaging 23(2):217–225CrossRef Channin DS, Mongkolwat P, Kleper V, Sepukar K, Rubin DL (2010) The caBIG annotation and image markup project. J Digit Imaging 23(2):217–225CrossRef
15.
go back to reference Clunie DA (2000) DICOM structured reporting. PixelMed Publishing, Bangor Clunie DA (2000) DICOM structured reporting. PixelMed Publishing, Bangor
16.
go back to reference Degtyarenko K, De Matos P, Ennis M, Hastings J, Zbinden M, McNaught A, Alcántara R, Darsow M, Guedj Ml, Ashburner M (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucl Acids Res 36(suppl 1):D344–D350 Degtyarenko K, De Matos P, Ennis M, Hastings J, Zbinden M, McNaught A, Alcántara R, Darsow M, Guedj Ml, Ashburner M (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucl Acids Res 36(suppl 1):D344–D350
17.
go back to reference Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang YU, Aldape K, Cha S, Kuo MD (2008) Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci 105(13):5213–5218CrossRef Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang YU, Aldape K, Cha S, Kuo MD (2008) Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci 105(13):5213–5218CrossRef
18.
go back to reference Eisenhauer EA, Bogaerts J, Therasse P, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247CrossRef Eisenhauer EA, Bogaerts J, Therasse P, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247CrossRef
19.
go back to reference ESR (2010) White paper on imaging biomarkers. Insights Imaging 1(2):42–45 ESR (2010) White paper on imaging biomarkers. Insights Imaging 1(2):42–45
20.
go back to reference Gene Ontology Consortium et al (2008) The gene ontology project in 2008. Nucl Acids Res 36(suppl 1):D440–D444 Gene Ontology Consortium et al (2008) The gene ontology project in 2008. Nucl Acids Res 36(suppl 1):D440–D444
22.
go back to reference Hewitt R, Watson P (2013) Defining biobank. Biopreserv Biobank 11(5):309–315CrossRef Hewitt R, Watson P (2013) Defining biobank. Biopreserv Biobank 11(5):309–315CrossRef
23.
go back to reference Horridge M, Tudorache T, Nuylas C, Vendetti J, Noy NF, Musen MA (2014) Webprotégé: a collaborative web-based platform for editing biomedical ontologies. Bioinformatics 30(16):2384–2385CrossRef Horridge M, Tudorache T, Nuylas C, Vendetti J, Noy NF, Musen MA (2014) Webprotégé: a collaborative web-based platform for editing biomedical ontologies. Bioinformatics 30(16):2384–2385CrossRef
24.
go back to reference Jaffer FA, Weissleder R (2005) Molecular imaging in the clinical arena. Jama 293(7):855–862CrossRef Jaffer FA, Weissleder R (2005) Molecular imaging in the clinical arena. Jama 293(7):855–862CrossRef
25.
go back to reference Jain R, Poisson LM, Gutman D, Scarpace L, Hwang SN, Holder CA, Wintermark M, Rao A, Colen RR, Kirby J et al (2014) Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology 272(2):484–493CrossRef Jain R, Poisson LM, Gutman D, Scarpace L, Hwang SN, Holder CA, Wintermark M, Rao A, Colen RR, Kirby J et al (2014) Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology 272(2):484–493CrossRef
26.
go back to reference Kelloff GJ, Bast RC, Coffey DS, DAmico AV, Kerbel RS, Park JW, Ruddon RW, Rustin GJS, Schilsky RL, Sigman CC et al (2004) Biomarkers, surrogate endpoints, and the acceleration of drug development for cancer prevention and treatment an update prologue. Clin Cancer Res 10(11):3881–3884CrossRef Kelloff GJ, Bast RC, Coffey DS, DAmico AV, Kerbel RS, Park JW, Ruddon RW, Rustin GJS, Schilsky RL, Sigman CC et al (2004) Biomarkers, surrogate endpoints, and the acceleration of drug development for cancer prevention and treatment an update prologue. Clin Cancer Res 10(11):3881–3884CrossRef
27.
go back to reference Kessler LG, Barnhart HX, Buckler AJ, Choudhury KR, Kondratovich MV, Toledano A, Guimaraes AR, Filice R, Zhang Z, Sullivan DC (2015) The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions. Stat Methods Med Res 24(1):9–26MathSciNetCrossRef Kessler LG, Barnhart HX, Buckler AJ, Choudhury KR, Kondratovich MV, Toledano A, Guimaraes AR, Filice R, Zhang Z, Sullivan DC (2015) The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions. Stat Methods Med Res 24(1):9–26MathSciNetCrossRef
28.
go back to reference Malone J, Holloway E, Adamusiak T, Kapushesky M, Zheng J, Kolesnikov N, Zhukova A, Brazma A, Parkinson H (2010) Modeling sample variables with an experimental factor ontology. Bioinformatics 26(8):1112–1118CrossRef Malone J, Holloway E, Adamusiak T, Kapushesky M, Zheng J, Kolesnikov N, Zhukova A, Brazma A, Parkinson H (2010) Modeling sample variables with an experimental factor ontology. Bioinformatics 26(8):1112–1118CrossRef
29.
go back to reference Mungall C, Gkoutos G, Washington N, Lewis S (2007) Representing phenotypes in OWL. In: Golbreich C, Kalyanpur A, Parsia B (eds) Proceedings of the OWLED 2007 workshop on OWL: experience and directions, Innsbruck, Austria Mungall C, Gkoutos G, Washington N, Lewis S (2007) Representing phenotypes in OWL. In: Golbreich C, Kalyanpur A, Parsia B (eds) Proceedings of the OWLED 2007 workshop on OWL: experience and directions, Innsbruck, Austria
30.
go back to reference O’Connor JPB, Jackson A, Asselin MC, Buckley DL, Parker GJM, Jayson GC (2008) Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives. Lancet Oncol 9(8):766–776CrossRef O’Connor JPB, Jackson A, Asselin MC, Buckley DL, Parker GJM, Jayson GC (2008) Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives. Lancet Oncol 9(8):766–776CrossRef
31.
go back to reference Ofoghi B, Campos GHL, Verspoor K, Sanchez FJM (2014) BiomRKRS: a biomarker retrieval and knowledge reasoning system. In: Proceedings of the seventh Australasian workshop on health informatics and knowledge management, vol 153. Australian Computer Society, Inc, pp 31–39 Ofoghi B, Campos GHL, Verspoor K, Sanchez FJM (2014) BiomRKRS: a biomarker retrieval and knowledge reasoning system. In: Proceedings of the seventh Australasian workshop on health informatics and knowledge management, vol 153. Australian Computer Society, Inc, pp 31–39
32.
go back to reference Rosse C, José LV, Mejino JR (2003) A reference ontology for biomedical informatics: the foundational model of anatomy. J Biomed Inform 36(6):478–500CrossRef Rosse C, José LV, Mejino JR (2003) A reference ontology for biomedical informatics: the foundational model of anatomy. J Biomed Inform 36(6):478–500CrossRef
34.
go back to reference Rubin DL, Rodriguez C, Shah P, Beaulieu CF (2008) iPad: semantic annotation and markup of radiological images. In: AMIA Rubin DL, Rodriguez C, Shah P, Beaulieu CF (2008) iPad: semantic annotation and markup of radiological images. In: AMIA
35.
go back to reference Scheuermann RH, Ceusters W, Smith B (2009) Toward an ontological treatment of disease and diagnosis. Summit Transl Bioinform 2009:116 Scheuermann RH, Ceusters W, Smith B (2009) Toward an ontological treatment of disease and diagnosis. Summit Transl Bioinform 2009:116
39.
go back to reference Wagner JA, Williams SA, Webster CJ (2007) Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther 81(1):104–107CrossRef Wagner JA, Williams SA, Webster CJ (2007) Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther 81(1):104–107CrossRef
40.
go back to reference Xiang Z, Courtot M, Brinkman RR, Ruttenberg A, He Y (2010) Ontofox: web-based support for ontology reuse. BMC Res Notes 3(1):175CrossRef Xiang Z, Courtot M, Brinkman RR, Ruttenberg A, He Y (2010) Ontofox: web-based support for ontology reuse. BMC Res Notes 3(1):175CrossRef
Metadata
Title
Imaging Biomarker Ontology (IBO): A Biomedical Ontology to Annotate and Share Imaging Biomarker Data
Authors
Emna Amdouni
Bernard Gibaud
Publication date
10-09-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal on Data Semantics / Issue 4/2018
Print ISSN: 1861-2032
Electronic ISSN: 1861-2040
DOI
https://doi.org/10.1007/s13740-018-0093-3

Premium Partner